Hypermethylation of SHISA3 DNA as a blood-based biomarker for colorectal cancer

Hypermethylation of SHISA3 DNA as a blood-based biomarker for colorectal cancer

In Taiwan, colorectal cancer (CRC) is the second most common cancer and the cancer with the third highest mortality rate. This may be because of the difficulty of detecting the disease in the early stages, as well as the fact that colonoscopy, a typical method used in screening for CRC, causes disco...

Full description

Bibliographic Details
Main Authors: Sheng-Hui Tang, Cheng-Wen Hsiao, Wei-Liang Chen, Li-Wei Wu, Jin-Biou Chang, Bing-Heng Yang
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Chinese Journal of Physiology
Subjects:
colorectal cancer
hypermethylation
shisa3
Online Access:http://www.cjphysiology.org/article.asp?issn=0304-4920;year=2021;volume=64;issue=1;spage=51;epage=56;aulast=Tang

Internet

http://www.cjphysiology.org/article.asp?issn=0304-4920;year=2021;volume=64;issue=1;spage=51;epage=56;aulast=Tang

Similar Items